LYMPHANGIOLEIOMYOMATOSIS (LAM) - QUESTIONS (Letter to the Editor and Response)

A Szuba; R Gupta; FX McCormack

Articles

LYMPHANGIOLEIOMYOMATOSIS (LAM) - QUESTIONS (Letter to the Editor and Response)

Authors: A Szuba ( ) , R Gupta ( ) , FX McCormack ( )

Abstract

Letter to the Editor and Response

Keywords: lymphangioleiomyomatosis (LAM), sporadic LAM, tuberous sclerosis LAM, vascular endothelial growth factors (VEGF), angiomyolipoma (AML), sirolimus (Rapamycin)

How to Cite: Szuba, A. , Gupta, R. & McCormack, F. (2015) “LYMPHANGIOLEIOMYOMATOSIS (LAM) - QUESTIONS (Letter to the Editor and Response)”, Lymphology. 48(1).